| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-11-06 | 2009-09-30 | 13F-HR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 0 | Sold All | -423,755 | -100 % | - | - | - | -2.95 % | $563,594 | | | | | | History of Copper Rock Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-08-04 | 2009-06-30 | 13F-HR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 423,755 | Sold Some | -345,382 | -44.90 % | $19,068,975 | $18,518,094 | $-550,882 | -2.88 % | $448,997 | | | | | | History of Copper Rock Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-08 | 2009-03-31 | 13F-HR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 769,137 | Added More | 177,780 | 30.06 % | $26,350,634 | $33,611,287 | $7,260,653 | 27.55 % | $1,678,243 | | | | | | History of Copper Rock Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-01-30 | 2008-12-31 | 13F-HR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 591,357 | Sold Some | -232,432 | -28.21 % | $21,803,333 | $25,842,301 | $4,038,968 | 18.52 % | $-1,587,511 | | | | | | History of Copper Rock Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2008-11-07 | 2008-09-30 | 13F-HR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 823,789 | Added More | 250,541 | 43.70 % | $33,775,349 | $35,999,579 | $2,224,230 | 6.58 % | $676,461 | | | | | | History of Copper Rock Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2008-08-07 | 2008-06-30 | 13F-HR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 573,248 | Added More | 92,397 | 19.21 % | $51,775,759 | $25,050,938 | $-26,724,822 | -51.61 % | $-4,307,548 | | | | | | History of Copper Rock Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2008-05-01 | 2008-03-31 | 13F-HR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 480,851 | Sold Some | -237,542 | -33.06 % | $34,645,315 | $21,013,189 | $-13,632,126 | -39.34 % | $6,734,316 | | | | | | History of Copper Rock Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2008-02-12 | 2007-12-31 | 13F-HR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 718,393 | Added More | 448,546 | 166.22 % | $50,344,981 | $31,393,774 | $-18,951,207 | -37.64 % | $-11,832,643 | | | | | | History of Copper Rock Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2007-11-13 | 2007-09-30 | 13F-HR | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 269,847 | New Holding | 269,847 | 100 % | $19,828,358 | $11,792,314 | $-8,036,044 | -40.52 % | $-8,036,044 | | | | | | History of Copper Rock Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |